๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Cohort Study of Postoperative Cognitive Dysfunction After Off-Pump Coronary Artery Bypass Grafting
NCT07643194Postoperative Cognitive Dysfunction (POCD)
Beijing Anzhen Hospital
Observational
600
Beijing
2026-05-24
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
644
Beijing, Changzhou, Chongqing, Guangzhou, Huai'an, Ningbo, Shijiazhuang, Zhuzhou
2026-05-23
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT07525206Colorectal Cancer
AbbVie
Phase 3
990
Beijing, Guangzhou, Nanning, Wuhan, Changchun, Shenyang, Yinchuan, Jinan
2026-05-22
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843Crohn Disease
Janssen Research & Development, LLC
Phase 3
460
Beijing, Changzhou, Chongqing, Guangzhou, Hangzhou, Huai'an, Ningbo, Zhuzhou
2026-05-22
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
NCT07492641HR+/HER2- Breast Cancer
BeOne Medicines
Phase 3
1,056
Bengbu, Beijing, Chongqing, Fuzhou, Guangzhou, Shantou, Nanning, Haikou
2026-05-22
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT07413939HER2-positive Breast Cancer
Hoffmann-La Roche
Phase 2/3
650
Nanjing, Shanghai, Beijing, Bengbu, Chengdu, Fuzhou, Guangzhou, HangzhouZhejiang
2026-05-21
Recruiting
Chinese Adults With Kidney Disease
NCT07522099Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G), IC-MPGN
ADARx Pharmaceuticals, Inc.
Phase 2
30
Shenzhen, Guiyang, Zhengzhou, Baotou, Wuxi, Yantai, Beijing, Shandong
2026-05-21
Recruiting
Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
NCT07614477Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd.
Phase 2
45
Beijing, Tianjin
2026-05-20
Active, closed
Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer
NCT07745322Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms
Peking University Cancer Hospital & Institute
Observational
270
Beijing
2026-05-20
Recruiting
Randomized Controlled Trial of Multi-Patient CT-Derived Digital Twin Anatomical Variability Training to Shorten the Clinical Learning Curve for Bronchoscopy
NCT07718451Bronchoscopy, Learning Curves and Outcomes of Simulation-based Training, Learning Curve
Gang Hou
Not applicable
110
Beijing
2026-05-20
Recruiting
A Clinical Study of HRS-5765 in Healthy Participants
NCT07551167Heart Failure
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
74
Beijing
2026-05-20
Recruiting
A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
NCT07547553Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Huahui Health
Phase 1/2
30
Bengbu, Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou
2026-05-19
Recruiting
A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome
NCT07406932Antisynthetase Syndrome, Interstitial Lung Disease (ILD)
China-Japan Friendship Hospital
Not applicable
80
Beijing
2026-05-18
Recruiting
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
NCT07604688Intracranial Dural Arteriovenous Fistula
Xuanwu Hospital, Beijing
Observational
10,050
Beijing
2026-05-18
Not yet open
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
NCT07586865Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall, Acute Myocardial Infarction With ST Elevation, Acute Myocardial Infarction of Left Ventricle
Beijing Northland Biotech. Co., Ltd.
Phase 2
189
Beijing
2026-05-18
Active, closed
A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC
NCT07556549Non-Small Cell Lung Cancer ALK-positive
Pfizer
Observational
50
Beijing
2026-05-18
Recruiting
A Study of TAK-755 in Adults With Acute Ischemic Stroke
NCT07392450Acute Ischemic Stroke
Takeda
Phase 2
222
Beijing, Nanyang, Xuzhou, Jinan, Liaocheng, Linyi, Datong, Linfen
2026-05-17
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Not yet open
The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.
NCT07592754Neuromyelitis Optica Spectrum Disease (NMOSD)
Chinese PLA General Hospital
Phase EARLY_PHASE1
18
Beijing
2026-05-15
Not yet open
Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome
NCT07518420Non-erosive Reflux Disease (NERD)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Not applicable
66
Beijing
2026-05-15
Not yet open
Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma
NCT07554482Extranodal NK/T-cell Lymphoma
Beijing Tongren Hospital
Phase 2
34
Beijing
2026-05-15
Not yet open
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
NCT07486648Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell), Advanced Non-small-cell Lung Cancer
Shanxi Province Cancer Hospital
Phase 1/2
53
Beijing, Taiyuan
2026-05-15
Recruiting
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
NCT07518147Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
438
Beijing
2026-05-15
Not yet open
A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants
NCT07559240Overweight, Obese
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
30
Beijing
2026-05-15
Recruiting
Comparison of Speaking Valve Trial and Capping Trial for Tracheostomy Decannulation in Stroke Patients
NCT07435727Stroke
Hongying Jiang, MD
Not applicable
120
Beijing
2026-05-15
Not yet open
Gait Retraining for Runners With Patellofemoral Pain
NCT07557797Patellofemoral Pain, PFP
Beijing Sport University
Not applicable
44
Beijing
2026-05-15
Recruiting
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
NCT07599670Alzheimer's Disease
AbbVie
Phase 1/2
210
Beijing, Guangzhou
2026-05-15
Not yet open
Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients
NCT07583173Heart Failure
China National Center for Cardiovascular Diseases
Phase 4
104
Beijing
2026-05-15
Not yet open
Study of IBI3016 in People With Mild or Moderate Hypertension Patients
NCT07556796Hypertension
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Beijing
2026-05-15
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Recruiting
Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
NCT07519044Stroke, Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Phase 4
868
Beijing, Shandong
2026-05-14
Recruiting
Levetiracetam for Seizure Prevention After Brain Tumor Surgery
NCT07239115Postoperative Seizures After Brain Tumor Surgery
Beijing Tiantan Hospital
Phase 3
558
Beijing
2026-05-14
Not yet open
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
NCT07630363Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
40
Beijing
2026-05-14
Recruiting
Multidimensional Dysfunction in Patients With Post-Intensive Care Syndrome in China
NCT07585578Post-Intensive Care Syndrome (PICS)
Hongying Jiang, MD
Observational
800
Huaibei, Beijing, Hunan, Henan
2026-05-12
Recruiting
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
NCT07444372Obstructive Sleep Apnea, Sleep Disorder (Disorder), Atrial Fibrillation (AF), Sleep Disordered Breathing (SDB)
Beijing Anzhen Hospital
Not applicable
658
Beijing, Fuzhou, Zhangzhou, Nanning, Langfang, Shijiazhuang, Xingtai, Harbin
2026-05-12
Recruiting
A Phase โ…ก/โ…ข Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer
NCT07462143Colorectal (Colon or Rectal) Cancer
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals
Phase 3
5,700
Beijing, Lanzhou, Foshan, Guangzhou, Harbin, Changsha, Baotou, Nanjing
2026-05-11
Recruiting
Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
NCT07379047GIST - Gastrointestinal Stromal Tumor, Advanced
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Shijiazhuang
2026-05-11
Not yet open
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures
NCT07575256PCL - Posterior Cruciate Ligament Deficiency, Posterior Cruciate Ligament Tear, PCL - Posterior Cruciate Ligament Rupture
Beijing Tsinghua Chang Gung Hospital
Not applicable
22
Beijing
2026-05-10
Not yet open
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
NCT07605624Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation, Tricuspid Regurgitation
Beijing Anzhen Hospital
Observational
5,500
Beijing
2026-05-10
Recruiting
Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset
NCT07747688Early Gastric Cancer
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-05-08
Recruiting
Dymista in Chinese Adolescents
NCT07597473Allergic Rhinitis Due to Allergens
Viatris Inc.
Phase 4
100
Beijing, Changsha, Chengdu, Dalian, Hangzhou, Nanchang, Shanghai, Taiyuan
2026-05-08
Recruiting
A Clinical Study of Cizutamig in Thyroid Eye Disease
NCT07597200Thyroid Eye Disease, TED
Candid Therapeutics
Phase 1
38
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Changsha, Wuhan, Nanchang
2026-05-08
Recruiting
Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
NCT07522151Locally Advanced Gastric or Gastroesophageal Junction Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3
874
Beijing
2026-05-07
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285AML, Refractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1
27
Beijing
2026-05-07
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
NCT07415031Solid Tumors
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Recruiting
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
NCT07316270AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous
Beijing Anzhen Hospital
Not applicable
646
Hefei, Beijing, Xiamen, Harbin, Changchun, Xi'an
2026-05-06
Not yet open
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
NCT07593365Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain Alleviation
Peking University People's Hospital
Not applicable
216
Beijing
2026-05-06
Not yet open
Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential Hypertension
NCT07577323Essential Hypertension
Xuanwu Hospital, Beijing
Not applicable
60
Beijing
2026-05-06
Recruiting
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571005Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571109Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Guangzhou, Shenzhen, Luoyang, Nanjing, Tianjin
2026-05-05
Recruiting
A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.
NCT07354022Locally Advanced or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 3
912
Beijing
2026-05-05
Recruiting
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
NCT07587099Coronary Heart Disease (CHD)
Gan Lijun
Not applicable
2,170
Beijing, Haikou, Harbin, Nanchang, Heze, Jinan, Jining, Liaocheng
2026-05-04
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC
Phase 1/2
280
Beijing, Guangzhou, Shanghai
2026-05-03
Recruiting
The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
NCT07187154Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
300
Beijing
2026-05-02
By invitation
Acute Kidney Injury in Critically Ill Patients
NCT07653321Acute Kidney Injury
Beijing Chao Yang Hospital
Observational
23,600
Beijing
2026-05-01
Not yet open
High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) for Hypertension: A Randomized Controlled Trial
NCT07566650Primary Hypertension
Xuanwu Hospital, Beijing
Not applicable
50
Beijing
2026-05-01
Not yet open
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment
NCT07514988Acute Coronary Syndromes (ACS)
China National Center for Cardiovascular Diseases
Not applicable
60
Beijing
2026-05-01
Not yet open
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
NCT07617675AKI - Acute Kidney Injury, Cardiac Surgical Procedures, Cardiopulmonary Bypass
China National Center for Cardiovascular Diseases
Phase 4
694
Beijing
2026-05-01
Not yet open
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
NCT07560358NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
204
Beijing
2026-05-01
By invitation
Prospective Randomized Controlled Study: Amimaitosai Injection Combined With Corticosteroids for Gastrointestinal aGVHD
NCT07803978Acute Gastrointestinal Graft-versus-host Disease
Chinese PLA General Hospital
Phase EARLY_PHASE1
60
Beijing
2026-05-01
Not yet open
Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis
NCT07603713Periodontitis
Longbio Pharma (Suzhou) Co., Ltd.
Phase 2
100
Beijing
2026-05-01
Not yet open
Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction๏ผˆELASTIC๏ผ‰
NCT07563673Cerebral Infarction, Thrombolysis
Beijing Chao Yang Hospital
Phase 4
210
Beijing
2026-05-01
Recruiting
Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy
NCT07668037Non-Small Cell Carcinoma of Lung, Immunotherapy, Advanced Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
600
Beijing
2026-05-01
Not yet open
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
NCT07498907Upper Tract Urothelial Carcinoma
Peking University First Hospital
Phase 2
192
Beijing
2026-05-01
Not yet open
Short-Course Online Adaptive Radiotherapy Combined With Chemotherapy, Targeted Therapy and Immunotherapy as Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer
NCT07581626Locally Advanced Rectal Cancer (LARC)
Chinese PLA General Hospital
Phase 2
60
Beijing
2026-05-01
Not yet open
Prospective, Randomized, Parallel-Controlled Study of Brain Computer Interface Integrated Robotic Mirror Therapy for Post-Stroke Upper Limb Motor Function Disorder
NCT07553416Ischemic Stroke, Intracranial Haemorrhage, Brain-Computer Interfaces, Rehabilitation Exercise
Beijing Tiantan Hospital
Not applicable
40
Beijing
2026-05-01
Not yet open
Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis
NCT07515066Idiopathic Pulmonary Fibrosis (IPF)
Huan Ye
Phase 1
9
Beijing
2026-05-01
Not yet open
Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients
NCT07553793Pancreatic Cancer, Advanced Stage Cancer
Peking Union Medical College Hospital
Phase 1
18
Beijing
2026-05-01
Not yet open
IL13Rฮฑ2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma
NCT07481721Recurrent Malignant Glioma
Ming Yang
Phase 1
24
Beijing
2026-05-01
Recruiting
Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis
NCT07499791Chronic Dacryocystitis
Beijing Tongren Hospital
Phase 2
40
Beijing
2026-05-01
Not yet open
Effects of Resistance-based Exercise Snacks With Varying Fragmentation Patterns on Lower Limb Function and Executive Cognition in Pre-frail Older Adults
NCT07551206Effects of Exercise on Older Adults
Capital University of Physical Education and Sports, China
Not applicable
60
Beijing
2026-05-01
Not yet open
LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients
NCT07521488Coronary Artery Bypass Grafting, Heart Valve Disease, Aortic Aneurysm, Aortic Dissection
Beijing Anzhen Hospital
Not applicable
500
Beijing
2026-05-01
Recruiting
RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma
NCT07590024Nasopharyngeal Carcinoma (NPC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
651
Beijing
2026-05-01
Recruiting
GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity
NCT07633639Obesity
China-Japan Friendship Hospital
Not applicable
200
Beijing
2026-05-01
Not yet open
Antagonism of Neostigmine in Continuous Infusion of Mivacurium
NCT07524959Neuromuscular Blocking Agents
Beijing Tongren Hospital
Not applicable
120
Beijing
2026-05-01
Not yet open
Clinical Study of i-PRF Intrauterine Perfusion for Endometrial Regeneration and Repair in Moderate to Severe Intrauterine Adhesions
NCT07536971Intrauterine Adhesions
Beijing Obstetrics and Gynecology Hospital
Not applicable
200
Beijing
2026-05-01
Not yet open
Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)
NCT07553728Infertility
Changchun GeneScience Pharmaceutical Co., Ltd.
Observational
200
Beijing
2026-05-01
Not yet open
Effects of Music Therapy on Anxiety Symptoms in Patients With Prolonged Mechanical Ventilation: A Randomized Controlled Trial
NCT07560384Anxiety, Prolonged Mechanical Ventilation
Capital Medical University
Not applicable
200
Beijing
2026-05
Not yet open
Diagnostic Performance and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy in Diagnosing Tuberculous Mediastinal Lymphadenitis: a Randomised Controlled Trial
NCT07459569Tuberculosis, Mediastinal and Hilar Lymph Node Enlargement
China-Japan Friendship Hospital
Not applicable
108
Beijing
2026-05
Not yet open
An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia
NCT07584057Cancer Cachexia
Yunnan Baiyao Group Co., Ltd.
Phase 1/2
146
Beijing
2026-05
Not yet open
Maternal-Fetal Heart Sound/Electrocardiogram Monitoring and Cardiac Risk Early Warning
NCT07526662Pregnancy-Associated Heart Disease, Fetal Congenital Heart Disease, Autoimmune-Related Fetal Heart Block, Perinatal Adverse Events
Yihua He,MD
Observational
1,000
Beijing
2026-05
Not yet open
A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
NCT07557927Discoid Lupus Erythematosus
Kunming Pharmaceuticals, Inc.
Phase 2
100
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shenyang, Kunming, Hangzhou
2026-04-30
Not yet open
A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma
NCT07520357Advanced Neuroendocrine Carcinoma
Beijing GoBroad Hospital
Phase 2
23
Beijing
2026-04-30
Not yet open
A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD
NCT07269769AMD
Tasly Pharmaceutical Group Co., Ltd
Phase 3
450
Beijing
2026-04-30
Recruiting
A Study in Adults With Desmoid Tumors
NCT07541430Desmoid Tumor
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 2
50
Beijing
2026-04-30
Recruiting
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
NCT07423533Rheumatoid Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
450
Beijing
2026-04-30
Not yet open
A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
NCT07468396Prostate Cancer
Gan & Lee Pharmaceuticals.
Phase 1
65
Beijing
2026-04-30
Not yet open
BR101 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07537049Multiple Myeloma (MM)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
10
Beijing
2026-04-30
Recruiting
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
NCT07579936Postmenopausal Women With Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
200
Beijing
2026-04-30
Recruiting
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
NCT07571161Alzheimer Disease
Eli Lilly and Company
Phase 3
140
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei
2026-04-30
Recruiting
A Phase โ… b/โ…กa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
NCT07593027Pulmonary Arterial Hypertension PAH
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
Phase 1/2
120
Beijing, Jilin City, Fuzhou, Xiamen, Lanzhou, Guangzhou, Guiyang, Zhengzhou
2026-04-30
Not yet open
A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
NCT07485595Depression
Tasly Pharmaceutical Group Co., Ltd
Phase 2/3
180
Beijing
2026-04-30
Recruiting
LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
NCT07362186Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited
Phase 3
400
Beijing
2026-04-30
Recruiting
Exosome Therapy for Male Androgenetic Alopecia
NCT07693244Androgenetic Alopecia (AGA)
Zhang Han
Phase 2
120
Beijing
2026-04-30
Recruiting
The Effect of Sequential Therapy on Alzheimer's Disease
NCT07768579Mild Cognitive Impairment Due to Alzheimer Disease, Alzheimer Disease
Dongzhimen Hospital, Beijing
Observational
600
Beijing
2026-04-30
Recruiting
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer
NCT07670273Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-29
Recruiting
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062Non-Small-Cell Lung
AstraZeneca
Observational
3,000
Beijing
2026-04-29
Recruiting
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer
NCT07497386Unresectable Locally Recurrent Breast Cancer, Unresectable Locally Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
150
Beijing
2026-04-28
Rows per page Showing 601–700 of 5484
Previous 5 6 7 8 9 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=7

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.